Botanix Pharmaceuticals (BOT) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period 3 reasons to buy this surging ASX All Ords healthcare share todayApril 2 at 5:12 PM | msn.comBotanix Pharmaceuticals Issues New Securities as Part of Employee Incentive SchemeApril 2 at 5:08 AM | tipranks.comThese fundies outperformed this quarter thanks to gold and small capsMarch 31, 2025 | afr.comASX Growth Stocks With High Insider Ownership That Stand OutMarch 25, 2025 | finance.yahoo.comThe ASX pharmas playing the long game, with commercialisation the prizeMarch 18, 2025 | msn.comBotanix climbs into ASX 300 club, strengthening its global dermatology ambitionsMarch 13, 2025 | msn.comLong Shortz with Botanix Pharmaceuticals : a new major milestoneMarch 11, 2025 | msn.comHealth Check: Poly oh no! Polynovo shares resume slide as CEO goesMarch 10, 2025 | msn.comBotanix Pharmaceuticals Releases Business Overview and Forward-Looking StatementsMarch 10, 2025 | tipranks.comAnalysts Are Optimistic We'll See A Profit From Botanix Pharmaceuticals Limited (ASX:BOT)March 7, 2025 | finance.yahoo.comBotanix Pharmaceuticals Director Alters Shareholding StructureFebruary 27, 2025 | tipranks.comBotanix Pharmaceuticals Issues New Shares for Immediate TradingFebruary 27, 2025 | tipranks.comThis media company’s share price is tipped to doubleJanuary 23, 2025 | afr.comBotanix Pharmaceuticals’ Chair Adjusts Shareholding Amidst Strategic GrowthJanuary 16, 2025 | tipranks.comInsignia Financial Reduces Stake in Botanix PharmaceuticalsJanuary 14, 2025 | tipranks.comShenasaby Investments Ceases to be Substantial Holder in Botanix PharmaceuticalsJanuary 9, 2025 | tipranks.comBotanix Pharmaceuticals Issues New Unquoted Securities to Boost Employee IncentivesJanuary 9, 2025 | tipranks.comBotanix Pharmaceuticals Updates Director’s ShareholdingJanuary 9, 2025 | tipranks.com5 ASX All Ords shares starting the new year at 52-week highsJanuary 2, 2025 | msn.comFirst Sofdra prescriptions for excessive sweating condition pushes Botanix towards full commercial launchDecember 17, 2024 | msn.comHealth Check: Clinical trials don’t sleigh down for the silly seasonDecember 17, 2024 | msn.comBotanix Pharmaceuticals Prepares for Sofdra™ Market LaunchDecember 16, 2024 | tipranks.comAxillary Hyperhidrosis Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Patient Pool, and Companies DelveInsightDecember 12, 2024 | theglobeandmail.comThis ASX biotech stock could be the next M&A targetDecember 5, 2024 | afr.comBotanix Pharmaceuticals: Director’s Stock Interests SurgeDecember 3, 2024 | tipranks.comBotanix Pharmaceuticals Lists New Securities on ASXDecember 2, 2024 | tipranks.comThose who invested in Botanix Pharmaceuticals (ASX:BOT) three years ago are up 443%November 20, 2024 | finance.yahoo.comBotanix Pharmaceuticals to Present at Key Healthcare ConferenceNovember 19, 2024 | markets.businessinsider.comBotanix Pharmaceuticals Expands Sofdra™ Coverage in USNovember 14, 2024 | markets.businessinsider.comBiocurious: No sweat as Botanix tackles the world’s third-biggest skin disorderNovember 13, 2024 | msn.comBotanix Pharmaceuticals Passes Key AGM ResolutionsNovember 4, 2024 | markets.businessinsider.comBotanix Pharmaceuticals Poised for Market Impact with Sofdra LaunchNovember 3, 2024 | tipranks.comBotanix Pharmaceuticals Prepares for Sofdra LaunchOctober 28, 2024 | markets.businessinsider.comHere's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn SituationOctober 24, 2024 | finance.yahoo.comBreakeven Is Near for Botanix Pharmaceuticals Limited (ASX:BOT)September 28, 2024 | uk.finance.yahoo.comAlive and Kicking: No sweat as Botanix readies for US launch of its hyperhidrosis treatmentSeptember 17, 2024 | msn.comEvening Wrap: ASX 200 starts September on winning note as big bank rally extends, gold, uranium, and lithium stocks weakerSeptember 2, 2024 | msn.comBotanix Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 31, 2024 | finance.yahoo.comBotanix Pharmaceuticals Limited (BXPHF)July 27, 2024 | finance.yahoo.comTop performing funds: A high-conviction idea from a manager that delivered 35% in FY24July 23, 2024 | msn.comASX Growth Companies With High Insider Ownership Spotlight May 2024May 26, 2024 | finance.yahoo.comBotanix Pharmaceuticals Ltd BXPHFMay 15, 2024 | morningstar.comWe're Keeping An Eye On Botanix Pharmaceuticals' (ASX:BOT) Cash Burn RateApril 30, 2024 | finance.yahoo.comBotanix Pharmaceuticals Ltd.March 8, 2024 | wsj.comBotanix Pharmaceuticals Ltd (BOT)January 23, 2024 | investing.comIf you'd put $40,000 in this ASX healthcare stock at the start of 2023, you'd have $128,000 nowJanuary 23, 2024 | fool.com.auBotanix Pharmaceuticals Ltd BOTDecember 14, 2023 | morningstar.comBotanix Pharmaceuticals (ASX:BOT) shareholders have earned a 138% return over the last yearOctober 12, 2023 | finance.yahoo.comGuess which ASX cannabis share is crashing 36% following an FDA blowSeptember 26, 2023 | fool.com.auThis ASX cannabis stock is up 160% since June, and it has an FDA ruling coming up!September 20, 2023 | fool.com.au Remove Ads Get Botanix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BOT and its competitors with MarketBeat's FREE daily newsletter. Email Address BOT Media Mentions By Week BOT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BOT News Sentiment▼0.790.61▲Average Medical News Sentiment BOT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BOT Articles This Week▼30▲BOT Articles Average Week Remove Ads Get Botanix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BOT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MorphoSys News Today Genus News Today Oxford Nanopore Technologies News Today Biotest Aktiengesellschaft News Today PureTech Health News Today Oxford Biomedica News Today Faron Pharmaceuticals Oy News Today Aptose Biosciences News Today Fennec Pharmaceuticals News Today Cybin News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:BOT) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Botanix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Botanix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BOT Stock Free BOT Stock Alerts